LEADER Neoadjuvant Screening Trial: LCMC4 Evaluation of Actionable Drivers in Early Stage Lung Cancers
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Observational Trial
- Enrollment
- 1,000 patients (estimated)
- Sponsors
- Lung Cancer Mutation Consortium
- Collaborators
- Lung Cancer Research Foundation
- Trial Type
- Observational
- Last Update
- 2 weeks ago
- SparkCures ID
- 1710
- NCT Identifier
- NCT04712877
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.